Company Filing History:
Years Active: 2016
Title: Adam Wohl: Innovator in Taxane Silicate Prodrugs and Nanoparticles
Introduction
Adam Wohl is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on taxane silicate prodrugs and nanoparticles. His research focuses on enhancing the delivery and efficacy of therapeutic agents.
Latest Patents
Adam Wohl holds a patent for "Taxane silicate prodrugs and nanoparticles." This invention provides silicate prodrugs that comprise a therapeutic agent linked to one or more groups of formula (I): —Si(OR)(I). Each R independently has any of the values defined in the patent. Additionally, the invention includes nanoparticles comprising such compounds. This patent represents a significant advancement in drug delivery systems.
Career Highlights
Adam Wohl is affiliated with the University of Minnesota, where he conducts his research and development. His work has garnered attention for its potential applications in improving cancer treatment through enhanced drug delivery mechanisms. With a focus on innovative solutions, Wohl continues to contribute to the scientific community.
Collaborations
Adam Wohl has collaborated with esteemed colleagues such as Thomas R. Hoye and Christopher Ward Macosko. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
In summary, Adam Wohl is a dedicated inventor whose work on taxane silicate prodrugs and nanoparticles has the potential to revolutionize drug delivery systems. His contributions to the University of Minnesota and collaborations with fellow researchers highlight his commitment to innovation in the pharmaceutical industry.